# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-25-015880
Filing Date
2025-04-28
Accepted
2025-04-28 07:05:24
Documents
38
Period of Report
2025-04-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ef20048044_8k.htm iXBRL | 8-K | 31742
2 | EXHIBIT 99.1 | ef20048044_ex99-1.htm | EX-99.1 | 54264
6 | GRAPHIC | ef20048044_ex99-1slide1.jpg | GRAPHIC | 72300
7 | GRAPHIC | ef20048044_ex99-1slide2.jpg | GRAPHIC | 365305
8 | GRAPHIC | ef20048044_ex99-1slide3.jpg | GRAPHIC | 135974
9 | GRAPHIC | ef20048044_ex99-1slide4.jpg | GRAPHIC | 189999
10 | GRAPHIC | ef20048044_ex99-1slide5.jpg | GRAPHIC | 142912
11 | GRAPHIC | ef20048044_ex99-1slide6.jpg | GRAPHIC | 184629
12 | GRAPHIC | ef20048044_ex99-1slide7.jpg | GRAPHIC | 160672
13 | GRAPHIC | ef20048044_ex99-1slide8.jpg | GRAPHIC | 149210
14 | GRAPHIC | ef20048044_ex99-1slide9.jpg | GRAPHIC | 115216
15 | GRAPHIC | ef20048044_ex99-1slide10.jpg | GRAPHIC | 177394
16 | GRAPHIC | ef20048044_ex99-1slide11.jpg | GRAPHIC | 158134
17 | GRAPHIC | ef20048044_ex99-1slide12.jpg | GRAPHIC | 144868
18 | GRAPHIC | ef20048044_ex99-1slide13.jpg | GRAPHIC | 180629
19 | GRAPHIC | ef20048044_ex99-1slide14.jpg | GRAPHIC | 193176
20 | GRAPHIC | ef20048044_ex99-1slide15.jpg | GRAPHIC | 219264
21 | GRAPHIC | ef20048044_ex99-1slide16.jpg | GRAPHIC | 91749
22 | GRAPHIC | ef20048044_ex99-1slide17.jpg | GRAPHIC | 147848
23 | GRAPHIC | ef20048044_ex99-1slide18.jpg | GRAPHIC | 62641
24 | GRAPHIC | ef20048044_ex99-1slide19.jpg | GRAPHIC | 195428
25 | GRAPHIC | ef20048044_ex99-1slide20.jpg | GRAPHIC | 137942
26 | GRAPHIC | ef20048044_ex99-1slide21.jpg | GRAPHIC | 173877
27 | GRAPHIC | ef20048044_ex99-1slide22.jpg | GRAPHIC | 173219
28 | GRAPHIC | ef20048044_ex99-1slide23.jpg | GRAPHIC | 150838
29 | GRAPHIC | ef20048044_ex99-1slide24.jpg | GRAPHIC | 66166
| Complete submission text file | 0001140361-25-015880.txt |  | 5460735

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | gyre-20250428.xsd | EX-101.SCH | 4024
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | gyre-20250428_lab.xml | EX-101.LAB | 21966
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | gyre-20250428_pre.xml | EX-101.PRE | 16072
41 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20048044_8k_htm.xml | XML | 4205

Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 25875922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)